You’re Losing Patients
Before — and After — They Book
Sky Outreach’s AI + SDR automation answers every GLP-1/weight-loss inquiry within minutes, books qualified consultations, and keeps enrolled patients engaged, closing both the response gap and the adherence gap that drain recurring program revenue.
The Problems Weight Loss & GLP-1 Clinics Face
These challenges cost clinics real revenue every month. The figures on this page are published research and FDA data, not estimates.
Nearly Half of Inbound Calls Go Unanswered
A study of 7,000 calls across 22 medical practices in 18 states found 42% went missed; a broader industry figure puts unanswered medical-practice calls at roughly 23%. Either way, a real share of GLP-1 inquiries never reach a human.
Motivated Patients Don't Wait
80% of callers who reach voicemail hang up without leaving a message. A patient who calls a competing GLP-1 provider and gets a text response within 4 minutes simply books there instead — high ad spend and real demand quietly drain through a slow first response.
A Missed Inquiry Is a ~$1,200 Loss, Not a Minor One
Industry estimates put average lost revenue per missed weight-loss-program call at roughly $1,200, higher than a typical single-visit medical practice, since a GLP-1 enrollment is a recurring monthly program, not a one-time visit.
The Real Challenge Starts After the First Visit: Adherence
Published research shows roughly 65% of GLP-1 patients without type 2 diabetes (about 47% of those with diabetes) discontinue within one year, and about 85% are no longer taking it after two years. A clinic that wins the lead but loses the patient at month three hasn't actually solved its revenue problem.
Stopping Treatment Undoes the Result
Patients who stop a GLP-1 regain roughly two-thirds of their lost weight within a year. That's exactly why ongoing engagement and retention, not just the first booked consult, is what protects both patient outcomes and recurring clinic revenue.
The Compounding Pharmacy Landscape Shifted in 2025
The FDA removed semaglutide and tirzepatide from its drug-shortage list in 2025 and wound down mass compounding of both (503A pharmacies by spring 2025), pushing many patients toward $1,000+/month brand-name pricing or narrower personalized-dose exceptions. Clinics need to communicate this shift clearly and offer a compliant path forward.
Dosing Safety Is a Real, Documented Risk
The FDA has logged 455+ adverse event reports tied to compounded semaglutide and 320+ for compounded tirzepatide, many involving dosing errors from patients self-administering incorrect doses from multidose vials, which is why proper clinical intake, not just fast response, matters in this category.
Pricing Varies Sharply by State and Channel
Consultation fees, program costs, and lab work can swing by as much as 40% depending on state, and cash-pay program pricing itself ranges from $99/month (compounded telehealth) to $1,350/month (full brand-name retail). A lead that isn't qualified on budget and fit wastes real clinical time.
A Full Patient Acquisition & Retention System
Designed for Every Program Type
How the Automation Works, Start to Finish
From first contact to an engaged, enrolled patient, fully automated.
Lead Captured
From a web form, ad, referral, or inbound call, any hour of the day.
AI Responds Instantly
Replies within minutes, closing the gap that sends motivated patients to a faster-responding competitor.
AI Collects Info
Treatment history, budget signals, and program-fit questions.
AI Qualifies
Program fit and readiness — before clinical or front-desk time is spent.
Auto-Booking
Qualified patients are booked directly into the clinic's calendar.
Structured Reminders
SMS, email, and call reminders trigger on a schedule built to reduce no-shows.
Patient Shows & Enrolls
The patient completes intake and enrolls in a program.
Adherence Check-Ins & Recovery
Automated follow-up supports ongoing engagement post-enrollment, and a recovery flow re-engages any missed appointment.
A Busy Clinic, Modeled
Not a real client outcome. A model built from the same benchmarks used in the calculator below, shown transparently rather than as a promised result.
Key Features Built for Weight Loss & GLP-1 Clinics
Instant AI Response
Responds to inbound leads within minutes, not the hours many clinics currently take.
Program-Based Qualification
Custom flows for compounded, brand-name, and membership program inquiries.
Missed-Call Recovery
Automatically calls or texts back any lead that isn't caught live.
Automated Scheduling
Direct integration with the clinic's calendar system.
No-Show Prevention
Multi-channel reminder workflows built to reduce missed appointments.
Adherence Check-In Automation
Scheduled post-enrollment touchpoints designed to support retention, not just the initial booking.
Lead Attribution
Know exactly which marketing source drives each booked, shown consultation.
End-to-End Reporting
Full visibility into the lead-to-enrolled-patient funnel.
Multilingual Support
Reach patients in the language they're most comfortable in.
Baseline vs. Instant Response
What’s typical across GLP-1/weight-loss clinics, and what instant, structured follow-up is built to capture.
Built With Healthcare Regulations and This Category’s Specific Risks in Mind
HIPAA-Conscious Communication
Every patient interaction follows healthcare privacy best practices.
No Medical Advice
The AI handles administrative and appointment information only — never treatment recommendations, dosing guidance, or diagnoses; clinical questions are routed to a licensed provider.
Sourcing-Aware Messaging
Following the FDA's 2025 wind-down of mass compounded GLP-1 production, the system is built to help clinics communicate sourcing and pricing changes accurately rather than leave patients guessing.
Consent Before Automation
Proper consent is obtained before any communication sequence is triggered, consistent with TCPA expectations for calls and texts.
For the full governance and audit framework behind these safeguards, see Trust & Compliance.
Calculate Your Clinic’s Potential Revenue
An illustrative estimate — slider ranges and defaults are grounded in published 2026 U.S. market data (see sources below), not invented figures. This models first-month recurring program revenue from newly enrolled patients only, not multi-month retention value — adjust the program value to reflect your own pricing. See audited case studies for verified client outcomes.
Where These Numbers Come From
- 22-practice, 18-state, 7,000-call medical-practice missed-call study: 42% of calls went missed; a broader industry figure separately cites ~23% of medical-practice calls going unanswered, and 80% of callers reaching voicemail don't leave a message
- Industry estimates for medically-supervised weight-loss programs: average revenue lost per missed service call of roughly $1,200 (a directional industry figure, not a single authoritative body's published statistic)
- Published GLP-1 discontinuation research: roughly 65% of non-diabetic and 47% of diabetic patients discontinue within 1 year; ~85% have discontinued by 2 years; patients who stop typically regain about two-thirds of lost weight within a year
- FDA drug-shortage and compounding-policy updates (2025): semaglutide removed from the shortage list February 2025, tirzepatide removed December 2024; mass compounding of both wound down through spring 2025 (503A deadlines April-May 2025); 455+ adverse event reports tied to compounded semaglutide and 320+ for compounded tirzepatide, many involving dosing errors from self-administered multidose vials
- Published 2026 cash-pay GLP-1 pricing data: compounded telehealth programs run $99-$449/month all-inclusive (Cora Health, Lemonaid Health, GobyMeds, Eden, Henry Meds); manufacturer-savings-card brand pricing runs $199-$349/month ongoing (Novo Nordisk); full brand-name retail runs $1,000-$1,350/month (Wegovy ~$1,350, Zepbound ~$1,271); clinical-care costs surrounding the medication (consults, labs, program fees) can swing up to 40% by state
- Show rate (81% default) reuses this site's Medspa calculator's peer-reviewed medical-clinic benchmark (a 10-clinic study found a mean no-show rate of 18.8%) as the closest available proxy. No GLP-1-clinic-specific no-show study was found, disclosed honestly rather than presented as GLP-1-specific data
- Consult-booking rate (50%) and enrollment rate (45%) are general proxies, not GLP-1-clinic-specific published figures. No vertical-specific study on either stage was found; disclosed honestly rather than presented as sourced data
Frequently Asked Questions
Is it really true that nearly half of medical-practice calls go unanswered?
A study of 7,000 calls across 22 practices in 18 states found 42% went missed, and a broader industry figure separately cites roughly 23% of medical-practice calls going unanswered. Either figure means a meaningful share of GLP-1 inquiries never reach a human, and 80% of callers who hit voicemail hang up without leaving a message.
Why does this page talk about patient retention, not just lead response?
Because the data shows that's where GLP-1 programs actually lose the most value. Roughly 65% of non-diabetic patients discontinue within a year, and patients who stop typically regain about two-thirds of the weight they lost within a year, so winning the lead without supporting ongoing adherence only solves half the revenue problem.
Will the AI give dosing or medical advice to patients?
No. The AI only handles intake and administrative information: program structure, pricing ranges, and scheduling. It never provides dosing guidance, treatment recommendations, or diagnoses; clinical questions are routed to a licensed provider.
What happened with compounded GLP-1 medications in 2025?
The FDA removed semaglutide and tirzepatide from its drug-shortage list in 2025 and wound down mass compounding of both, meaning many clinics and patients shifted toward brand-name pricing (with or without manufacturer savings programs) or narrower personalized-dose compounding exceptions. This system is built to help clinics communicate that shift accurately, not obscure it.
How fast can a weight-loss/GLP-1 clinic launch this?
Typically 7–14 days, covering onboarding, system configuration, integration setup, and team training.
What channels does the AI respond on?
Phone, SMS, Email, WhatsApp, Instagram DM, Facebook Messenger, and website chat, all unified in one dashboard.
Where do the numbers on this page come from?
Missed-call and discontinuation figures come from published research and FDA data cited in the sources list near the calculator. Consult-booking and enrollment rates in the calculator are general proxies, not GLP-1-specific — no vertical-specific study on either stage was found, and that's disclosed rather than presented as sourced data.
What kind of return can a weight-loss clinic expect?
Results vary by program pricing, patient mix, and market. The calculator above is built to be transparent and adjustable rather than a single promised number. See the Case Studies page for verified before/after results from other industries.
Ready to Stop Losing Patients Before — and After — They Book?
See how the automation works for your specific program mix and patient volume.